Pet-ct in evaluation of pulmonary nodule - Case report;Zastosowanie pet-tk w diagnostyce guza płuca - Opis przypadku

Polski Merkuriusz Lekarski

Volumn 27, Issue 158, 2009, Pages 119-122

  Tadeusz, M Zielonka ^a   Jacek, Pietrzykowski ^b   Kazimierz, A Wardyn ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Clear cell type renal carcinoma; Computed tomography; Positron emission tomography; Pulmonary nodule

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; KIDNEY TUMOR; LUNG DISEASE; LUNG NODULE; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING; SECOND CANCER; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA, CLEAR CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KIDNEY NEOPLASMS; LUNG DISEASES; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SOLITARY PULMONARY NODULE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349594829     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. (Pubitemid 30173877) Bakheet S. M., Saleem M., Powe J. i wsp: F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection. Clin. Nucl. Med., 2000, 25, 273-278.
2. (Pubitemid 24106447) Brudin L. H., Valind S. O., Rhodes C. G. i wsp: Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur. J. Nucl. Med., 1994, 21, 297-305.
3. Daniels C. E., Lowe V. J., Aubry M. C. i wsp: The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Chest, 2007, 131, 255-260.
4. Dewan N. A., Gupta N. C., Redepenning L. S. i wsp: Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest, 1993, 104, 997-1002.
5. Duhaylongsod F. G., Lowe V. J., Patz E. F. i wsp: Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J. J. Thorac. Cardiovasc. Surg., 1995, 110, 130-139.
6. Gambhir S. S., Shepherd J. E., Shah B. D. i wsp: Analytical decision model for the cost-effective management of solitary pulmonary nodules. J. Clin. Oncol., 1998, 16, 2113-2125.
7. Gould M. K., Maclean C. C., Kuschner W. G. i wsp: Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA, 2001, 285, 914-924.
8. (Pubitemid 28063165) Higashi K., Nishikawa T., Seki H. i wsp: Comparison of fluorine-18-FDG PET and thallium-201 SPECTin evaluation of lung cancer. J. Nucl. Med., 1998, 39, 9-15.
9. (Pubitemid 28270118) Higashi K., Ueda Y., Seki H. i wsp: Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J. Nucl. Med., 1998, 39, 1016-1020.
10. Hyun O. J., Yoo I. R., Kim S. H. i wsp: Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies. J. J. Nucl. Med., 2007, 58, 15-21.
11. (Pubitemid 38196188) Jadvar H., Kherbache H. M., Pinski J. K. i wsp: Diagnostic role of[F-18]-FDG positron emission tomography in restaging renal cell carcinoma. Clin. Nephrol., 2003, 60, 395-400.
12. Jeong Y. J., Yi C. A., Lee K. S.: Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment. Am. J. Roentgenol., 2007, 188, 57-68.
13. (Pubitemid 38501007) Kang D. E., White R. L. Jr., Zuger J. H. i wsp: Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J. Urol., 2004, 171, 1806-1809.
14. Kapucu L. O., Meltzer C. C., Townsend D. W. i wsp: Fluorine-18- fluorodeoxyglucose uptake in pneumonia. J. Nucl. Med., 1998, 39, 1267-1269.
15. (Pubitemid 40675199) Lam J. S., Shvarts O., Leppert J. T. i wsp: Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J. Urol., 2005, 173, 1853-1862.
16. Larscheid R. C., Thorpe P. E., Scott W. J.: Percutaneous transthoracic needle aspiration biopsy: a comprehensive review of its current role in the diagnosis and treatment of lung tumors. C. Chest, 1998, 114, 704-709.
17. (Pubitemid 26196919) Li H., Boiselle P. M., Shepard J. O. i wsp: Diagnostic accuracy and safety of CT-guided percutaneous needle aspiration biopsy of the lung: comparison of small and large pulmonary nodules. A. Am. J. Roentgenol., 1996, 167, 105-109.
18. (Pubitemid 46606214) Majhail N. S., Urbain J. L., Albani J. M. i wsp: F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma. J. J. Clin. Oncol., 2003, 21, 3995-4000.
19. (Pubitemid 34309961) Miyakita H., Tokunaga M., Onda H. i wsp: Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. I. Int. J. Urol., 2002, 9, 15-18.
20. (Pubitemid 30490393) Pieterman R. M., van Putten J. W., Meuzelaar J. J. i wsp: Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N. Engl. J. Med., 2000, 343, 254-261.
21. (Pubitemid 34275883) Piltz S., Meimarakis G., Wichmann M. W. i wps.: Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann. Thorac. Surg., 2002, 73, 1082-1087.
22. (Pubitemid 34071627) Safaei A., Figlin R., Hoh C. K. i wsp: The usefulness of F-18 fluorodeoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. C. Clin. Nephrol., 2002, 57, 56-62.
23. (Pubitemid 27349433) Santambrogio L., Nosotti M., Bellaviti N. i wsp: CT-guided fine-needle aspiration cytology of solitary pulmonary nodules: a prospective, randomized study of immediate cytologic evaluation. C. Chest, 1997, 112, 423-425.
24. (Pubitemid 43115334) Shiono S., Yoshida J., Nishimura M. i wsp: Late pulmonary metastasis of renal cell carcinoma resected 25 years after nephrectomy. Jpn. J. Clin. Oncol., 2004, 34, 46-49.
25. Sivaramakrishna B., Gupta N. P., Wadhwa P. i wsp: Pattern of metastases in renal cell carcinoma: a single institution study. Indian J. Cancer, 2005, 42, 173-177.
26. Steele J. D., Kleitsch W. P., Dunn J. E. Jr. i wsp: Survival in males with bronchogenic carcinomas resected as asymptomatic solitary pulmonary nodules. Ann. Thorac. Surg., 1966, 2, 368-376.
27. (Pubitemid 27051740) Steinert H. C., Hauser M., Allemann F. i wsp: Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. R. Radiology, 1997, 202, 441-446.
28. (Pubitemid 36135711) Toloza E. M., Harpole L, McCrory D. C.: Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest, 2003, 123, supl. 1, 137S-146S.
29. (Pubitemid 32492571) Vansteenkiste J. F., Stroobants S. G.: The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology. Eur. Respir. J., 2001, 17, 802-820.
30. Vansteenkiste J. F., Stroobants S. G., Dupont P. J. i wsp: FDG-PET scan in potentially operable non-small cell lung cancer do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? Eur. J. J. Nucl. Med., 1998, 25, 1495-1501.
31. Watanabe A., Ohsawa H., Obama T. i wsp: Node dissection for solitary interlobar node metastasis from renal cell carcinoma by VATS. Ann. Thorac. Cardiovasc. Surg., 2005, 11, 38-40.
32. Yankelevitz D. F., Henschke C. I.: Does 2-year stability imply that pulmonary nodules are benign? Am. J. Roentgenol., 1997, 168, 325-328.
33. Yi C. A., Lee K. S., Kim B. T. i wsp: Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. J. J. Nucl. Med., 2006, 47, 443-450.